Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chetan H Mehta

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Biomolecular Structure & Dynamics|October 4, 2021
Identification of novel small molecule inhibitors for endoplasmic reticulum oxidoreductase 1α (ERO1α) enzyme: structure-based molecular docking and molecular dynamic simulation studiesHussam Albassam, Chetan H Mehta, Usha Y Nayak
Drug Discovery Today|May 1, 2020
Multiple approaches for achieving drug solubility: an in silico perspectiveTorsa Das, Chetan H Mehta, Usha Y Nayak
World Journal of Microbiology & Biotechnology|July 19, 2021
Structurally nanoengineered antimicrobial peptide polymers: design, synthesis and biomedical applicationsRonisha Ramamurthy, Chetan H Mehta, Usha Y Nayak
Current Pharmaceutical Design|July 8, 2020
Long-Acting Formulations: A Promising Approach for the Treatment of Chronic DiseasesSomaraju R Kumar, Chetan H Mehta, Usha Y Nayak
Expert Opinion on Drug Delivery|September 24, 2021
Advances and challenges in nintedanib drug deliveryVaralakshmi Velagacherla, Akhil Suresh, Chetan H Mehta, et al.
World Journal of Microbiology & Biotechnology|August 2, 2020
Antimicrobial peptide polymers: no escape to ESKAPE pathogens-a reviewSonghita Mukhopadhyay, A S Bharath Prasad, Chetan H Mehta, et al.
AAPS Pharmscitech|July 1, 2025
Hot Melt Extruded Aceclofenac-Soluplus® Solid Dispersion: Mechanistic View of Miscibility and Drug-Carrier Interactions for Enhanced DissolutionLikhitha U, Roushan Bharti, Reema Narayan, et al.
Current Pharmaceutical Design|May 5, 2023
Controlled Release Technologies for Chronotherapy: Current Status and Future PerspectivesBhavana B Bhat, Chetan H Mehta, Akhil Suresh, et al.
European Journal of Pharmacology|February 4, 2021
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing studyKrishnaprasad Baby, Swastika Maity, Chetan H Mehta, et al.
Archives of Medical Research|September 23, 2020
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing StudyKrishnaprasad Baby, Swastika Maity, Chetan H Mehta, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Biomolecular Structure & Dynamics|October 4, 2021
Identification of novel small molecule inhibitors for endoplasmic reticulum oxidoreductase 1α (ERO1α) enzyme: structure-based molecular docking and molecular dynamic simulation studiesHussam Albassam, Chetan H Mehta, Usha Y Nayak
Drug Discovery Today|May 1, 2020
Multiple approaches for achieving drug solubility: an in silico perspectiveTorsa Das, Chetan H Mehta, Usha Y Nayak
World Journal of Microbiology & Biotechnology|July 19, 2021
Structurally nanoengineered antimicrobial peptide polymers: design, synthesis and biomedical applicationsRonisha Ramamurthy, Chetan H Mehta, Usha Y Nayak
Current Pharmaceutical Design|July 8, 2020
Long-Acting Formulations: A Promising Approach for the Treatment of Chronic DiseasesSomaraju R Kumar, Chetan H Mehta, Usha Y Nayak
Expert Opinion on Drug Delivery|September 24, 2021
Advances and challenges in nintedanib drug deliveryVaralakshmi Velagacherla, Akhil Suresh, Chetan H Mehta, et al.
World Journal of Microbiology & Biotechnology|August 2, 2020
Antimicrobial peptide polymers: no escape to ESKAPE pathogens-a reviewSonghita Mukhopadhyay, A S Bharath Prasad, Chetan H Mehta, et al.
AAPS Pharmscitech|July 1, 2025
Hot Melt Extruded Aceclofenac-Soluplus® Solid Dispersion: Mechanistic View of Miscibility and Drug-Carrier Interactions for Enhanced DissolutionLikhitha U, Roushan Bharti, Reema Narayan, et al.
Current Pharmaceutical Design|May 5, 2023
Controlled Release Technologies for Chronotherapy: Current Status and Future PerspectivesBhavana B Bhat, Chetan H Mehta, Akhil Suresh, et al.
European Journal of Pharmacology|February 4, 2021
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing studyKrishnaprasad Baby, Swastika Maity, Chetan H Mehta, et al.
Archives of Medical Research|September 23, 2020
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing StudyKrishnaprasad Baby, Swastika Maity, Chetan H Mehta, et al.
Pageof 2